日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High-throughput 3D phenotypic screening identifies repurposed MEK inhibitors as drivers of chondrogenesis for cartilage regeneration

高通量3D表型筛选鉴定出重新利用的MEK抑制剂可作为软骨形成和软骨再生的驱动因子

Hajiali, Hadi; Cholewa-Waclaw, Justyna; Ballard, Jacob; Okur, Kerime Ebrar; Elliott, Richard; Carragher, Neil O; El Haj, Alicia J

Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma.

靶向 FAK 和 MEK 的药物组合克服了胶质母细胞瘤的肿瘤异质性

Furqan Muhammad, Elliott Richard J R, Nagle Peter W K, Dawson John C, Masalmeh Roza, Garcia Virginia Alvarez, Munro Alison F, Drake Camilla, Morrison Gillian M, Pollard Steven M, Ebner Daniel, Brunton Valerie G, Frame Margaret C, Carragher Neil O

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma

高通量筛选鉴定组蛋白去乙酰化酶抑制剂在软组织肉瘤患者模型中的活性

Danks, Molly R; Manasterski, Piotr J; Beetham, Henry; Dawson, John C; Elliott, Richard J R; Culley, Jayne; Krishna, Rashi; Muir, Morwenna; Thomson, John P; Oswald, Ailsa J; Ewing, Ailith; Kerrison, William G J; Huang, Paul H; Nixon, Ioanna; Carragher, Neil O; Brunton, Valerie G

Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma

基因组学主导的药物测试方法在未分化多形性肉瘤模型中的应用

Manasterski, Piotr J; Danks, Molly R; Thomson, John P; Muir, Morwenna; Lee, Martin; Dawson, John C; Amaral, Ana T; Diaz-Martin, Juan; Moura, David S; Martin-Broto, Javier; Alsaadi, Ali; Salter, Donald M; Oswald, Ailsa J; Grimes, Graeme; Hayward, Larry; Hupp, Ted R; Sisley, Karen; Huang, Paul H; Carragher, Neil O; Brunton, Valerie G

Cellular Activity of CQWW Nullomer-Derived Peptides

CQWW Nullomer衍生肽的细胞活性

Shave, Steven; Isaksson, Rebecka; Pham, Nhan T; Elliott, Richard J R; Dawson, John C; Soudant, Julius; Carragher, Neil O; Auer, Manfred

High content 3D imaging by dual-view oblique plane microscopy

双视角斜平面显微镜高内涵3D成像

Sparks, Hugh; Rowe-Brown, Leo; Alexandrov, Yuriy; Gustafsson, Nils; Dvinskikh, Liuba; Curry, Nathan; Culley, Jayne; Lee, Martin; Le Marois, Alix; Ratcliffe, Colin D H; Phillips, Thomas A; Owczarek, Claudia; Arias Garcia, Mar; Llanses, Montserrat; Suckert, Theresa; Pelletier, Joffrey; Cortina, Carme; Hong, Wenzhi; Garcia, Edwin; Xu, Zhizhen; Zhang, Shengjie; Stassi, Giorgio; Batlle, Eduard; Colombelli, Julien; Parsons, Maddy; Bakal, Chris; Carragher, Neil O; Sahai, Erik; Dunsby, Chris

The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas

SRC家族激酶抑制剂NXP900在鳞状细胞癌中表现出强大的抗肿瘤活性。

Dash, Sweta; Hanson, Sabrina; King, Ben; Nyswaner, Katherine; Foss, Kelcie; Tesi, Noelle; Harvey, Mungo J B; Navarro-Marchal, Saúl A; Woods, Allison; Poradosu, Enrique; Unciti-Broceta, Asier; Carragher, Neil O; Brognard, John

Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer

以配体为中心、基于表型的强效激酶抑制剂研发治疗食管癌

Ayala-Aguilera, Cecilia C; Ge, Yang; Lorente-Macías, Álvaro; Jones, Benjamin N; Adam, Catherine; Carragher, Neil O; Unciti-Broceta, Asier

A Novel High-Content Phenotypic Screen To Identify Inhibitors of Mitochondrial DNA Maintenance in Trypanosomes

一种新型高通量表型筛选方法用于鉴定锥虫线粒体DNA维持抑制剂

Miskinyte, Migla; Dawson, John C; Makda, Ashraff; Doughty-Shenton, Dahlia; Carragher, Neil O; Schnaufer, Achim

Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia

胶质母细胞瘤及学术界对非假设驱动型联合疗法的探索

Johanssen, Timothy; McVeigh, Laura; Erridge, Sara; Higgins, Geoffrey; Straehla, Joelle; Frame, Margaret; Aittokallio, Tero; Carragher, Neil O; Ebner, Daniel